Evidence map›Paper›PMID 35543240›Full record

ArticleJournal of applied toxicology : JAT2022

Assessment of inhalation toxicity of cigarette smoke and aerosols from flavor mixtures: 5-week study in A/J mice.

Ee Tsin Wong, Karsta Luettich, Lydia Cammack, Chin Suan Chua, David Sciuscio, Celine Merg, Maica Corciulo, Romain Piault, Kumar Ashutosh, Cameron Smith and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of applied toxicology : JAT, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. NAM journal · 2025
    Article
  4. The Toxicological Effects of e-Cigarette Use in the Upper Airway: A Scoping Review.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2024
    Article
  5. Article
  6. Chemical andToxicology reports · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 2 countries.

Ee Tsin WongPMI R&D, Philip Morris International Research Laboratories Pte Ltd, Singapore.ORCID 0000-0003-0967-1305
Karsta LuettichPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Lydia CammackPMI R&D, Philip Morris International Research Laboratories Pte Ltd, Singapore.
Chin Suan ChuaPMI R&D, Philip Morris International Research Laboratories Pte Ltd, Singapore.
David SciuscioPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.ORCID 0000-0002-8835-9434
Celine MergPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Maica CorciuloPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Romain PiaultPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Kumar AshutoshAltria Client Services LLC, Richmond, Virginia, USA.
Cameron SmithAltria Client Services LLC, Richmond, Virginia, USA.
Patrice LeroyPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Fabian MoinePMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Anneke GlabasniaPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Pierrick DianaPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Cecilia ChiaPMI R&D, Philip Morris International Research Laboratories Pte Ltd, Singapore.
Ching Keong TungPMI R&D, Philip Morris International Research Laboratories Pte Ltd, Singapore.
Nikolai IvanovPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Julia HoengPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Manuel PeitschPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Kyeonghee Monica LeeAltria Client Services LLC, Richmond, Virginia, USA.
Patrick VanscheeuwijckPMI R&D, Philip Morris Products S.A, Neuchâtel, Switzerland.
Philip Morris International (Switzerland) · CHAltria (United States) · US

Funding

Altria Client Services LLCPhilip Morris Products S.A.
6 · The paper itself

Abstract

Most flavors used in e-liquids are generally recognized as safe for oral consumption, but their potential effects when inhaled are not well characterized. In vivo inhalation studies of flavor ingredients in e-liquids are scarce. A structure-based grouping approach was used to select 38 flavor group representatives (FGR) on the basis of known and in silico-predicted toxicological data. These FGRs were combined to create prototype e-liquid formulations and tested against cigarette smoke (CS) in a 5-week inhalation study. Female A/J mice were whole-body exposed for 6 h/day, 5 days/week, for 5 weeks to air, mainstream CS, or aerosols from (1) test formulations containing propylene glycol (PG), vegetable glycerol (VG), nicotine (N; 2% w/w), and flavor (F) mixtures at low (4.6% w/w), medium (9.3% w/w), or high (18.6% w/w) concentration or (2) base formulation (PG/VG/N). Male A/J mice were exposed to air, PG/VG/N, or PG/VG/N/F-high under the same exposure regimen. There were no significant mortality or in-life clinical findings in the treatment groups, with only transient weight loss during the early exposure adaptation period. While exposure to flavor aerosols did not cause notable lung inflammation, it caused only minimal adaptive changes in the larynx and nasal epithelia. In contrast, exposure to CS resulted in lung inflammation and moderate-to-severe changes in the epithelia of the nose, larynx, and trachea. In summary, the study evaluates an approach for assessing the inhalation toxicity potential of flavor mixtures, thereby informing the selection of flavor exposure concentrations (up to 18.6%) for a future chronic inhalation study.

Indexed as

Cigarette SmokingAdministration, InhalationAerosolsAnimalsFemaleGlycerolMaleMiceMice, Inbred StrainsNicotianaPropylene GlycolAerosolsGlycerolPropylene GlycolE-cigaretteemphysemaflavor toolboxharm reductioninflammationinhalation

Identifiers

PMID35543240
PMCPMC9545811
OpenAlexW4280603068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.